In case anyone was wondering, it’s never good to be identified as a “middleman.” That’s the label being applied to pharmacy benefits managers who are being blamed for jacking up pharmaceutical prices through opaque agreements with pharmaceutical manufacturers and insurers, which allow the PBMs to negotiate substantial discounts without passing the savings along to […]